Clinical Trial Update: Immunogenicity, Safety and Tolerability of Prepandemic Influenza and Seasonal Influenza Vaccine in Adult Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the immunogenicity, safety and tolerability of a prepandemic and seasonal influenza vaccine in adults; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avian Influenza
• Pandemic Influenza

Drugs mentioned

• Prepandemic and Seasonal Influenza Vaccine (Novartis) (influenza vaccine)

Snippet

Sponsor: Novartis | Conditions: Pandemic, Avian Influenza | Phase 2 | Status: COMPLETED | Results posted: 2013-02-28